BofA Securities analyst Alec Stranahan maintains $SpringWorks Therapeutics (SWTX.US)$ with a buy rating, and adjusts the target price from $58 to $55.
According to TipRanks data, the analyst has a success rate of 42.3% and a total average return of -7.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $SpringWorks Therapeutics (SWTX.US)$'s main analysts recently are as follows:
Political and rate uncertainty continues to be a concern in the sector, however, the overall condition of the Biopharma sector is viewed as significantly better compared to the previous year's lows. The preference remains for companies in late-stage clinical or early launch phases, yet there is a growing interest in Phase 1 clinical programs that provide derisking data and have imminent catalysts.
The firm has modestly adjusted its estimates for Ogsiveo, taking into account reduced expectations for its impact on ovarian granulosa cell tumor contributions and anticipating a more gradual increase in sales in the EU by 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
